Company Short-Term Debt: maravai.com (MRVI)

Public company logo of Maravai LifeSciences Holdings, Inc. (MRVI)

Maravai LifeSciences (MRVI) is a leading developer of components for gene therapy and mRNA drugs, investing in the synthesis of ultra-pure acids. The market price trend shows that the indicator is 0.01. The company's revenues are based on B2B deals with biopharmaceutical behemoths for the supply of reagents. Meanwhile, the enterprise strictly adheres to chemical disposal standards, maintaining line sterility and optimizing energy consumption in its laboratories.

MRVI (Maravai LifeSciences Holdings, Inc.) Company Short-Term Debts history from 07/04/2022 to 11/01/2026

Analytical breakdowns and data insights for company Maravai (MRVI)

- stock price and consensus target price:
Stock Price Maravai LifeSciences Holdings, Inc.|MRVI - Analyst Consensus Forecast
- company stock exchange capitalization indicators:
Market Value Maravai LifeSciences Holdings, Inc.|MRVI - Business Value
- shareholders' equity book value data:
Book Value per Share Maravai LifeSciences|MRVI - Book Capitalization|Market Value to Book Value Ratio maravai.com|MRVI - Aggregate Company Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Maravai LifeSciences|MRVI - Long-Term Liabilities to Capital|Short-Term Debt to Equity Maravai LifeSciences|MRVI - Company Total Debt Obligations|Debts to Book Capitalization Maravai LifeSciences Holdings, Inc.|MRVI - Long-Term Debt Volume|Company Short-Term Debt Maravai LifeSciences|Quick Liquidity maravai.com
- net income and valuation multiples indicators:
MRVI - Net Income
Fundamental company analysis:Maravai LifeSciences Holdings, Inc. (MRVI)
Flagship merchandise of Maravai LifeSciences

Asset quality assessment begins with an analysis of liquidity and the structure of liabilities. This indicator measures the volume of debt maturing within one year, reflecting management's ability to manage operational cash flow. The dynamics of financial liabilities with a maturity of up to 12 months allow for the tracking of payment discipline and borrowing costs. For Maravai LifeSciences (MRVI), this metric confirms the transparency of capital management, which is critically important for business diversification in the post-pandemic era.

Competitors of Maravai LifeSciences

Agilent - Company Short-Term Debts|DGX - Company Short-Term Debts|Illumina Corp (ILMN) - Company Short-Term Debt|Company Short-Term Indebtedness EXAS|RVTY (Revvity, Inc.) - Company Short-Term Debts|Company Short-Term Debts bio-rad.com|Company Short-Term Debt Anbio (NNNN)|Company Short-Term Debt SHC (Sotera Health Corp)|QuidelOrtho Corp - Company Current Liabilities|OPKO Health Corp. (OPK) - Short-Term Debt|CDNA - Company Short-Term Debt|Short-Term Debt Volume fulgentgenetics.com FLGT|LAB: Company Short-Term Debts|CTKB - Short-Term Debt Volume|Company Short-Term Debt OraSure Technologies Inc|Exagen Diagnostics (XGN) - Short-Term Debt Volume|Company Short-Term Debt MDxHealth SA (MDXH)|Company Current Liabilities luciddx.com LUCD|Company Short-Term Debts PRE (Prenetics)|Company Short-Term Debts Insight Molecular Diagnostics, Inc. IMDX|TRIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings PRPH (ProPhase Labs Corp)|AIMD: Company Short-Term Debts|codiagnostics.com (CODX) - Company Short-Term Debts|Company Current Liabilities HSCS|Company Short-Term Debt BMRA|Company Short-Term Debts CDIO|Company Short-Term Debts Virax Biolabs Corp (VRAX)|Company Short-Term Debts BJDX (Bluejay Diagnostics)|Short-Term Debt Volume aspirawh.com (AWH)|AXDX: Company Current Liabilities|Company Short-Term Loans and Borrowings CNTG (CENTOGENE N.V.)|enzo.com (ENZ) - Company Short-Term Debt|FRES (Fresh2 Group) - Company Short-Term Debt|GENE (Genetic Technologies Ltd) - Company Short-Term Debts|23andme.com (ME) - Short-Term Debt Volume|Company Short-Term Debts PMD